Literature DB >> 8226725

Translational control by influenza virus. Selective translation is mediated by sequences within the viral mRNA 5'-untranslated region.

M S Garfinkel1, M G Katze.   

Abstract

In cells infected by influenza virus type A, host cell protein synthesis declines rapidly and dramatically, while influenza viral protein synthesis occurs efficiently throughout infection. Previously, we had shown that the selective translation of influenza viral mRNAs in infected cells occurred in a cap-dependent manner and was due at least in part to structures inherent in the mRNAs. Using chimeras containing the noncoding and coding regions of cellular and viral mRNAs, we can now report that the selective translation is mediated by sequences within the 5'-untranslated regions (UTR) of the viral mRNAs. Polysome analysis confirmed that a 45-nucleotide sequence contained in the 5'-UTR of the influenza viral nucleocapsid protein was necessary and sufficient to allow the host cell translational machinery to discriminate between viral and cellular mRNAs. In reciprocal experiments in which the 5'-UTR of the cellular mRNA-secreted embryonic alkaline phosphatase replaced the nucleocapsid protein 5'-UTR, viral protein synthesis was inhibited in virus-infected cells, resembling host protein synthesis. Finally, we demonstrated that the 5'-UTR of another influenza viral mRNA, that encoding the nonstructural protein, also conferred resistance to the shutoff of protein synthesis in influenza virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226725

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Picornavirus internal ribosome entry site elements target RNA cleavage events induced by the herpes simplex virus virion host shutoff protein.

Authors:  M M Elgadi; J R Smiley
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Polyuridylated mRNA synthesized by a recombinant influenza virus is defective in nuclear export.

Authors:  L L Poon; E Fodor; G G Brownlee
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 3.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

4.  Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity.

Authors:  T Zürcher; R M Marión; J Ortín
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Inhibition of host translation by virus infection in vivo.

Authors:  René Toribio; Iván Ventoso
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

6.  Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus.

Authors:  T Aragón; S de la Luna; I Novoa; L Carrasco; J Ortín; A Nieto
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  Selective translation of eukaryotic mRNAs: functional molecular analysis of GRSF-1, a positive regulator of influenza virus protein synthesis.

Authors:  John C Kash; Dawn M Cunningham; Maria W Smit; Youngwoo Park; David Fritz; Jeffrey Wilusz; Michael G Katze
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  trans regulation of cap-independent translation by a viral subgenomic RNA.

Authors:  Ruizhong Shen; Aurélie M Rakotondrafara; W Allen Miller
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

9.  Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II.

Authors:  A Rodriguez; A Pérez-González; A Nieto
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

10.  Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein.

Authors:  Y Li; Y Yamakita; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.